Research Article
Neonatal Screening for Sickle Cell Disease in Congo
Table 3
Prevalence of sickle cell disease among newborns according to the departments of Congo between November 2019 and March 2020.
| Department | Total, n (%) | Carrier Hb AA, n (%) | Carrier Hb AS/AC, n (%) | MSS, n (%) |
| Bouendza | 113 (3.90) | 98 (86.7) | 13 (11.5) | 2 (1.77) | Brazzaville | 1560 (53.8) | 1241 (79.6) | 298 (19.1) | 21 (1.35) | Cuvette Centrale | 124 (4.28) | 92 (74.2) | 32 (25.8) | — | Cuvette-Ouest | 78 (2.69) | 60 (76.9) | 16 (20.5) | 2 (2.56) | Kouilou | 38 (1.31) | 34 (89.5) | 4 (10.5) | — | Lekoumou | 54 (1.86) | 42 (77.8) | 12 (22.2) | — | Likouala | 60 (2.07) | 54 (90.0) | 6 (10.0) | — | Niari | 179 (6.18) | 133 (74.3) | 44 (24.6) | 2 (1.12) | Plateau | 121 (4.18) | 98 (81.0) | 22 (18.2) | 1 (0.83) | Pointe Noire | 370 (12.8) | 280 (75.7) | 81 (21.9) | 9 (2.43) | Pool | 132 (4.56) | 101 (76.5) | 29 (22.0) | 2 (1.52) | Sangha | 68 (2.35) | 62 (91.2) | 6 (8.82) | — | Total | 2897 (100) | 2295 (79.21) | 563 (19.43) | 39 (1.35) |
|
|
MSS: major sickle cell syndrome (FS, FSE, and FSA). |